Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

IMPORTANCE: It has been hypothesized that angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) may make patients more susceptible to coronavirus disease 2019 (COVID-19) and to worse outcomes through upregulation of the functional receptor of the virus, angiotensin-co...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA
Glavni autori: Fosbøl, Emil L., Butt, Jawad H., Østergaard, Lauge, Andersson, Charlotte, Selmer, Christian, Kragholm, Kristian, Schou, Morten, Phelps, Matthew, Gislason, Gunnar H., Gerds, Thomas A., Torp-Pedersen, Christian, Køber, Lars
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2020
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305566/
https://ncbi.nlm.nih.gov/pubmed/32558877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.11301
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items